Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Joseph W LaPlume. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Joseph W LaPlume har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:CRL / Charles River Laboratories International, Inc. | EVP, Corp Strategy & Develop | 31 298 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Joseph W LaPlume. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CRL / Charles River Laboratories International, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CRL / Charles River Laboratories International, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | CRL | LaPlume Joseph W | 25 | 174,5400 | 25 | 174,5400 | 4 364 | 93 | 185.7900 | 282 | 6,46 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CRL / Charles River Laboratories International, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Joseph W LaPlume som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −235 | 31 298 | −0,75 | 180,71 | −42 467 | 5 655 862 | |
| 2026-06-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −744 | 31 533 | −2,31 | 180,71 | −134 448 | 5 698 328 | |
| 2026-06-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 5 257 | 32 277 | 19,46 | 180,71 | 949 992 | 5 832 777 | |
| 2026-05-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −185 | 27 020 | −0,68 | 156,73 | −28 995 | 4 234 845 | |
| 2026-05-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −243 | 27 205 | −0,89 | 160,30 | −38 953 | 4 360 962 | |
| 2026-03-04 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
P - Purchase | 25 | 27 448 | 0,09 | 174,54 | 4 364 | 4 790 774 | |
| 2026-02-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −1 749 | 27 423 | −6,00 | 211,68 | −370 228 | 5 804 901 | |
| 2026-02-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 5 456 | 29 172 | 23,01 | ||||
| 2026-01-20 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −400 | 23 716 | −1,66 | 163,72 | −65 488 | 3 882 784 | |
| 2025-08-20 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −800 | 24 116 | −3,21 | 157,60 | −126 080 | 3 800 682 | |
| 2025-08-08 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −400 | 24 916 | −1,58 | 150,04 | −60 016 | 3 738 397 | |
| 2025-06-09 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −385 | 25 316 | −1,50 | ||||
| 2025-06-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −155 | 25 701 | −0,60 | 135,63 | −21 023 | 3 485 827 | |
| 2025-06-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 6 709 | 25 856 | 35,04 | 135,63 | 909 942 | 3 506 849 | |
| 2025-05-29 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −83 | 19 147 | −0,43 | 138,65 | −11 508 | 2 654 732 | |
| 2025-05-29 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −122 | 19 230 | −0,63 | 136,73 | −16 681 | 2 629 318 | |
| 2025-05-29 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −161 | 19 352 | −0,83 | 136,73 | −22 014 | 2 645 999 | |
| 2025-05-15 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −500 | 19 513 | −2,50 | 145,41 | −72 705 | 2 837 385 | |
| 2025-02-21 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −4 400 | 20 013 | −18,02 | 162,50 | −715 000 | 3 252 112 | |
| 2025-02-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −846 | 24 413 | −3,35 | 165,57 | −140 072 | 4 042 060 | |
| 2025-02-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 2 738 | 25 259 | 12,16 | ||||
| 2024-08-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 780 | 22 521 | −7,32 | 199,36 | −354 861 | 4 489 787 | |
| 2024-06-04 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −311 | 24 301 | −1,26 | ||||
| 2024-06-03 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 2 111 | 24 612 | 9,38 | ||||
| 2024-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −223 | 22 501 | −0,98 | 214,51 | −47 836 | 4 826 690 | |
| 2024-05-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −125 | 22 724 | −0,55 | 217,21 | −27 151 | 4 935 880 | |
| 2024-05-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −184 | 22 849 | −0,80 | 217,21 | −39 967 | 4 963 031 | |
| 2024-05-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −243 | 23 033 | −1,04 | 217,21 | −52 782 | 5 002 998 | |
| 2024-05-14 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 304 | 23 276 | −5,31 | 226,97 | −295 969 | 5 282 954 | |
| 2024-03-25 |
|
4/A | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −994 | 25 418 | −3,76 | 220,28 | −218 958 | 5 599 077 | |
| 2024-03-25 |
|
4/A | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 3 279 | 26 412 | 14,17 | ||||
| 2024-02-20 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −838 | 24 620 | −3,29 | 238,93 | −200 223 | 5 882 457 | |
| 2024-01-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −1 025 | 25 458 | −3,87 | 220,28 | −225 787 | 5 607 888 | |
| 2024-01-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 3 350 | 26 483 | 14,48 | ||||
| 2023-12-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 850 | 23 133 | −7,41 | 197,73 | −365 800 | 4 574 088 | |
| 2023-11-13 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −6 543 | 24 983 | −20,75 | 173,76 | −1 136 912 | 4 341 046 | |
| 2023-11-13 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −2 585 | 31 526 | −7,58 | 172,77 | −446 610 | 5 446 747 | |
| 2023-11-13 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 9 128 | 34 111 | 36,54 | 144,67 | 1 320 548 | 4 934 838 | |
| 2023-08-14 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −700 | 24 983 | −2,73 | 216,52 | −151 564 | 5 409 319 | |
| 2023-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −223 | 25 683 | −0,86 | 194,12 | −43 289 | 4 985 584 | |
| 2023-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −125 | 25 906 | −0,48 | 194,12 | −24 265 | 5 028 873 | |
| 2023-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −184 | 26 031 | −0,70 | 194,12 | −35 718 | 5 053 138 | |
| 2023-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 2 189 | 26 215 | 9,11 | ||||
| 2023-05-16 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −345 | 24 026 | −1,42 | 190,39 | −65 685 | 4 574 310 | |
| 2023-05-15 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −9 | 24 371 | −0,04 | 194,07 | −1 747 | 4 729 680 | |
| 2023-05-15 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −950 | 24 380 | −3,75 | 193,02 | −183 369 | 4 705 828 | |
| 2023-02-22 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −317 | 25 330 | −1,24 | 243,60 | −77 221 | 6 170 388 | |
| 2023-01-30 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −3 261 | 25 647 | −11,28 | 244,29 | −796 630 | 6 265 306 | |
| 2023-01-30 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 8 676 | 28 908 | 42,88 | ||||
| 2022-12-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 106 | 20 232 | −5,18 | 224,85 | −248 684 | 4 549 169 | |
| 2022-12-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −4 165 | 21 338 | −16,33 | 224,41 | −934 684 | 4 788 544 | |
| 2022-12-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 138 | 25 503 | −4,27 | 223,06 | −253 837 | 5 688 572 | |
| 2022-12-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 6 409 | 26 641 | 31,68 | 109,34 | 700 760 | 2 912 927 | |
| 2022-11-07 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −534 | 20 232 | −2,57 | 216,36 | −115 536 | 4 377 396 | |
| 2022-08-08 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −200 | 20 766 | −0,95 | 226,13 | −45 227 | 4 695 901 | |
| 2022-08-08 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −195 | 20 966 | −0,92 | ||||
| 2022-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −223 | 21 161 | −1,04 | 244,41 | −54 503 | 5 171 960 | |
| 2022-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −125 | 21 384 | −0,58 | 244,41 | −30 551 | 5 226 463 | |
| 2022-05-31 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 1 657 | 21 509 | 8,35 | ||||
| 2022-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −395 | 19 852 | −1,95 | 292,75 | −115 636 | 5 811 673 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −315 | 20 247 | −1,53 | 289,58 | −91 218 | 5 863 126 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −392 | 20 562 | −1,87 | 290,83 | −114 007 | 5 980 129 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −4 | 20 954 | −0,02 | 290,81 | −1 163 | 6 093 633 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −317 | 20 958 | −1,49 | 293,61 | −93 074 | 6 153 478 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −743 | 0 | −100,00 | ||||
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 143 | 21 275 | −5,10 | 291,80 | −333 527 | 6 208 045 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 743 | 22 418 | 3,43 | 88,05 | 65 421 | 1 973 905 | |
| 2022-02-23 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −150 | 21 675 | −0,69 | ||||
| 2022-02-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −4 570 | 21 825 | −17,31 | 312,24 | −1 426 937 | 6 814 638 | |
| 2022-02-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 11 344 | 26 395 | 75,37 | ||||
| 2021-12-27 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 6 771 | 15 051 | 81,78 | ||||
| 2021-12-27 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −182 | 8 280 | −2,15 | ||||
| 2021-08-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −300 | 8 462 | −3,42 | 409,40 | −122 820 | 3 464 343 | |
| 2021-08-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 042 | 8 762 | −10,63 | 402,43 | −419 335 | 3 526 118 | |
| 2021-08-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −900 | 9 804 | −8,41 | 401,66 | −361 498 | 3 937 914 | |
| 2021-08-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 458 | 10 704 | −11,99 | 400,91 | −584 522 | 4 291 309 | |
| 2021-06-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −223 | 12 162 | −1,80 | 337,99 | −75 372 | 4 110 634 | |
| 2021-06-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
A - Award | 3 476 | 3 476 | 337,99 | 1 174 853 | 1 174 853 | ||
| 2021-06-01 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 1 124 | 12 385 | 9,98 | ||||
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −2 750 | 743 | −78,73 | ||||
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −1 422 | 11 261 | −11,21 | 283,50 | −403 144 | 3 192 545 | |
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −967 | 12 683 | −7,08 | 282,27 | −272 951 | 3 579 978 | |
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −4 334 | 13 650 | −24,10 | 281,41 | −1 219 643 | 3 841 285 | |
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −2 012 | 17 984 | −10,06 | 280,75 | −564 877 | 5 049 082 | |
| 2021-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 2 750 | 19 996 | 15,95 | 88,05 | 242 138 | 1 760 648 | |
| 2021-02-25 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −322 | 17 246 | −1,83 | 282,98 | −91 120 | 4 880 273 | |
| 2021-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −315 | 17 568 | −1,76 | 283,59 | −89 331 | 4 982 109 | |
| 2021-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −317 | 17 883 | −1,74 | 289,55 | −91 787 | 5 178 023 | |
| 2021-02-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −4 708 | 18 200 | −20,55 | 260,88 | −1 228 223 | 4 748 016 | |
| 2021-02-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 11 862 | 22 908 | 107,39 | ||||
| 2021-02-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −310 | 11 046 | −2,73 | ||||
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −3 042 | 9 128 | −25,00 | ||||
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −3 205 | 6 409 | −33,34 | ||||
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −492 | 3 493 | −12,35 | ||||
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −3 520 | 11 356 | −23,66 | 251,18 | −884 144 | 2 852 369 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −580 | 14 876 | −3,75 | 250,23 | −145 133 | 3 722 407 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −2 639 | 15 456 | −14,58 | 249,09 | −657 350 | 3 849 946 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 3 042 | 18 095 | 20,21 | 144,67 | 440 086 | 2 617 804 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 3 205 | 15 053 | 27,05 | 109,34 | 350 435 | 1 645 895 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 492 | 11 848 | 4,33 | 88,05 | 43 321 | 1 043 216 | |
| 2020-11-05 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
G - Gift | −285 | 11 356 | −2,45 | ||||
| 2020-06-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
A - Award | 6 685 | 6 685 | |||||
| 2020-06-02 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 2 004 | 11 641 | 20,79 | ||||
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −350 | 9 637 | −3,50 | 174,65 | −61 128 | 1 683 113 | |
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −3 000 | 3 985 | −42,95 | ||||
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) |
M - Exercise | −3 350 | 0 | −100,00 | ||||
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −4 899 | 9 987 | −32,91 | 168,81 | −827 002 | 1 685 909 | |
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
S - Sale | −10 519 | 14 886 | −41,41 | 168,00 | −1 767 168 | 2 500 814 | |
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 3 000 | 25 405 | 13,39 | 88,05 | 264 150 | 2 236 910 | |
| 2020-05-19 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
M - Exercise | 3 350 | 22 405 | 17,58 | 73,70 | 246 895 | 1 651 248 | |
| 2020-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −303 | 19 055 | −1,57 | 162,46 | −49 225 | 3 095 675 | |
| 2020-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −322 | 19 358 | −1,64 | 173,64 | −55 912 | 3 361 323 | |
| 2020-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −315 | 19 680 | −1,58 | 173,64 | −54 697 | 3 417 235 | |
| 2020-02-24 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −317 | 19 995 | −1,56 | 173,64 | −55 044 | 3 471 932 | |
| 2020-02-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
F - Taxes | −3 846 | 20 312 | −15,92 | 159,07 | −611 783 | 3 231 030 | |
| 2020-02-10 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock |
A - Award | 10 745 | 24 158 | 80,11 | ||||
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 15 079 | −1,31 | 138,17 | −27 634 | 2 083 465 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −179 | 15 279 | −1,16 | 138,16 | −24 731 | 2 110 947 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −507 | 15 458 | −3,18 | 138,15 | −70 042 | 2 135 523 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 15 965 | −1,24 | 138,14 | −27 628 | 2 205 405 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −137 | 16 165 | −0,84 | 138,10 | −18 920 | 2 232 386 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −70 | 16 302 | −0,43 | 138,10 | −9 667 | 2 251 225 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −600 | 16 372 | −3,54 | 138,08 | −82 848 | 2 260 646 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 16 972 | −1,74 | 138,07 | −41 421 | 2 343 324 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −240 | 17 272 | −1,37 | 138,06 | −33 134 | 2 384 572 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −60 | 17 512 | −0,34 | 138,06 | −8 283 | 2 417 619 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −108 | 17 572 | −0,61 | 138,05 | −14 909 | 2 425 815 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 17 680 | −0,56 | 138,04 | −13 804 | 2 440 547 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 17 780 | −1,66 | 138,03 | −41 409 | 2 454 173 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −30 | 18 080 | −0,17 | 138,02 | −4 141 | 2 495 492 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 18 110 | −1,63 | 138,02 | −41 406 | 2 499 542 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −5 | 18 410 | −0,03 | 138,02 | −690 | 2 540 856 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −11 | 18 415 | −0,06 | 138,01 | −1 518 | 2 541 454 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 18 426 | −0,54 | 138,00 | −13 800 | 2 542 788 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −230 | 18 526 | −1,23 | 137,99 | −31 738 | 2 556 403 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 18 756 | −0,53 | 137,98 | −13 798 | 2 587 953 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −195 | 18 856 | −1,02 | 137,97 | −26 904 | 2 601 562 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 19 051 | −1,04 | 137,92 | −27 584 | 2 627 514 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −299 | 19 251 | −1,53 | 137,91 | −41 235 | 2 654 905 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 19 550 | −1,51 | 137,90 | −41 370 | 2 695 945 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 19 850 | −0,50 | 137,89 | −13 789 | 2 737 116 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 19 950 | −0,50 | 137,88 | −13 788 | 2 750 706 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 20 050 | −1,47 | 137,87 | −41 361 | 2 764 294 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −99 | 20 350 | −0,48 | 137,86 | −13 648 | 2 805 451 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 20 449 | −0,97 | 137,85 | −27 570 | 2 818 895 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 20 649 | −0,96 | 137,84 | −27 567 | 2 846 155 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) |
M - Exercise | −3 204 | 9 614 | −25,00 | ||||
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) |
M - Exercise | −3 492 | 6 985 | −33,33 | ||||
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) |
M - Exercise | −3 350 | 3 350 | −50,00 | ||||
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) |
M - Exercise | −1 542 | 0 | −100,00 | ||||
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 20 849 | −1,42 | 137,82 | −41 346 | 2 873 409 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −114 | 21 149 | −0,54 | 137,81 | −15 710 | 2 914 544 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 21 263 | −1,39 | 137,80 | −41 340 | 2 930 041 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 21 563 | −0,46 | 137,77 | −13 777 | 2 970 735 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 21 663 | −0,46 | 137,76 | −13 776 | 2 984 295 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 21 763 | −0,46 | 137,75 | −13 775 | 2 997 853 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 21 863 | −0,91 | 137,74 | −27 548 | 3 011 410 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 22 063 | −0,45 | 137,74 | −13 774 | 3 038 847 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −500 | 22 163 | −2,21 | 137,73 | −68 865 | 3 052 510 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 22 663 | −0,87 | 137,72 | −27 544 | 3 121 148 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 22 863 | −0,44 | 137,71 | −13 771 | 3 148 464 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −6 | 22 963 | −0,03 | 137,66 | −826 | 3 161 201 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 22 969 | −1,29 | 137,64 | −41 292 | 3 161 453 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −330 | 23 269 | −1,40 | 137,63 | −45 418 | 3 202 512 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −164 | 23 599 | −0,69 | 137,60 | −22 567 | 3 247 340 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 23 763 | −0,42 | 137,58 | −13 758 | 3 269 314 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 23 863 | −1,24 | 137,56 | −41 268 | 3 282 594 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −308 | 24 163 | −1,26 | 137,53 | −42 359 | 3 323 137 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 24 471 | −0,81 | 137,52 | −27 503 | 3 365 130 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 24 671 | −0,40 | 137,50 | −13 750 | 3 392 139 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −400 | 24 771 | −1,59 | 137,48 | −54 992 | 3 405 517 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −400 | 25 171 | −1,56 | 137,46 | −54 984 | 3 460 006 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −302 | 25 571 | −1,17 | 137,45 | −41 510 | 3 514 734 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −198 | 25 873 | −0,76 | 137,44 | −27 213 | 3 555 985 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 26 071 | −0,38 | 137,43 | −13 743 | 3 582 938 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 26 171 | −0,76 | 137,42 | −27 483 | 3 596 288 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
M - Exercise | 3 204 | 26 371 | 13,83 | 109,34 | 350 325 | 2 883 405 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
M - Exercise | 3 492 | 23 167 | 17,75 | 88,05 | 307 471 | 2 039 854 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
M - Exercise | 3 350 | 19 675 | 20,52 | 73,70 | 246 895 | 1 450 048 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
M - Exercise | 1 542 | 16 325 | 10,43 | 76,67 | 118 225 | 1 251 638 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 13 413 | −0,74 | 138,37 | −13 837 | 1 855 957 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −3 | 13 513 | −0,02 | 138,30 | −415 | 1 868 848 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 13 516 | −1,46 | 138,28 | −27 656 | 1 868 992 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 13 716 | −0,72 | 138,26 | −13 826 | 1 896 374 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −100 | 13 816 | −0,72 | 138,24 | −13 824 | 1 909 924 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 13 916 | −2,11 | 138,23 | −41 469 | 1 923 609 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 14 216 | −2,07 | 138,22 | −41 466 | 1 964 936 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −30 | 14 516 | −0,21 | 138,20 | −4 146 | 2 006 184 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −300 | 14 546 | −2,02 | 138,20 | −41 460 | 2 010 257 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −3 | 14 846 | −0,02 | 138,20 | −415 | 2 051 643 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −30 | 14 849 | −0,20 | 138,19 | −4 146 | 2 051 983 | |
| 2019-03-12 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
S - Sale | −200 | 14 879 | −1,33 | 138,18 | −27 636 | 2 055 980 | |
| 2019-02-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
F - Taxes | −156 | 14 783 | −1,04 | 140,71 | −21 951 | 2 080 116 | |
| 2019-02-28 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
F - Taxes | −304 | 14 939 | −1,99 | 145,31 | −44 174 | 2 170 786 | |
| 2019-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
F - Taxes | −322 | 15 243 | −2,07 | 144,67 | −46 584 | 2 205 205 | |
| 2019-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
F - Taxes | −316 | 15 565 | −1,99 | 144,67 | −45 716 | 2 251 789 | |
| 2019-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) |
A - Award | 12 170 | 12 170 | |||||
| 2019-02-26 |
|
4 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
A - Award | 2 854 | 15 881 | 21,91 | ||||
| 2019-02-07 | 3 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
26 054 | ||||||||
| 2019-02-07 | 3 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
26 054 | ||||||||
| 2019-02-07 | 3 | CRL |
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock |
26 054 |
